Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).
Saved in:
| Title: | Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1). |
|---|---|
| Authors: | Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Matsubara T; Department of Orthopedics, Matsubara Mayflower Hospital, Hyogo, Japan., Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Hokkaido, Japan., Amano K; Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Ishiguro N, Sugiyama E; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan., Yamaoka K; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Kanagawa, Japan., Combe BG; Rheumatology Department, CHU Montpellier, Montpellier University, Montpellier, France., Kivitz AJ; Altoona Center for Clinical Research, Duncansville, PA, USA., Bae SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea., Keystone EC; Department of Medicine, University of Toronto, Mount Sinai Hospital, Toronto, Canada., Nash P; Griffith University of Queensland, Brisbane, Australia., Matzkies F; Gilead Sciences Inc, Foster City, CA, USA., Bartok B; Gilead Sciences Inc, Foster City, CA, USA., Pechonkina A; Gilead Sciences Inc, Foster City, CA, USA., Kondo A; Gilead Sciences K.K, Gran Tokyo South Tower, Tokyo, Japan., Ye L; Gilead Sciences Inc, Foster City, CA, USA., Guo Y; Gilead Sciences Inc, Foster City, CA, USA., Tasset C; Galapagos NV, Mechelen, Belgium., Sundy JS; Gilead Sciences Inc, Foster City, CA, USA.; Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Aichi Developmental Disability Center, Aichi, Japan., Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. |
| Source: | Modern rheumatology [Mod Rheumatol] 2022 Feb 28; Vol. 32 (2), pp. 263-272. |
| Publication Type: | Clinical Trial, Phase III; Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN: 1439-7609 (Electronic) Linking ISSN: 14397595 NLM ISO Abbreviation: Mod Rheumatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
